Hasebe Takahiro, Sasaki Satoshi, Imoto Shigeru, Ochiai Atsushi
Pathology Division, The National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, Kashiwa, 277-8577 Chiba, Japan.
Virchows Arch. 2004 Jan;444(1):20-7. doi: 10.1007/s00428-003-0921-0. Epub 2003 Nov 18.
Invasive ductal carcinomas (IDCs) of the breast are composed of stroma-invasive tumors and tumors in vessels. The purpose of this study was to prospectively investigate whether the histological characteristics of the tumors in vessels were more significantly associated with the outcome of 393 IDC patients than well-known histological parameters. Multivariate analyses showed greater than six apoptotic figures in tumor cells in lymph vessels to be significantly associated with increased hazard rates (HRs) of tumor recurrence and death in IDC patients without nodal metastasis (P<0.05). Among IDC patients with nodal metastasis whose tumors were positive for estrogen receptors (ERs) or progesterone receptors (PRs) or both, greater than six apoptotic figures in tumor cells in lymph vessels and greater than four mitotic figures in tumor cells in lymph vessels significantly increased the HR of tumor recurrence and the HR of death, respectively (P<0.05). Among IDC patients with nodal metastases whose tumors were negative for ERs and PRs, multivariate analyses showed that greater than two apoptotic figures in the blood vessel tumor emboli significantly increased the HRs of tumor recurrence and death (P<0.005). We conclude that apoptotic figures and mitotic figures in tumor cells in vessels are very important prognostic indicators for patients with IDC of the breast.
乳腺浸润性导管癌(IDC)由间质浸润性肿瘤和血管内肿瘤组成。本研究的目的是前瞻性地调查血管内肿瘤的组织学特征与393例IDC患者的预后之间的关联是否比众所周知的组织学参数更为显著。多变量分析显示,在无淋巴结转移的IDC患者中,淋巴管内肿瘤细胞中凋亡细胞数大于6个与肿瘤复发和死亡风险率(HRs)增加显著相关(P<0.05)。在肿瘤雌激素受体(ERs)或孕激素受体(PRs)或两者均为阳性的有淋巴结转移的IDC患者中,淋巴管内肿瘤细胞中凋亡细胞数大于6个和淋巴管内肿瘤细胞中有丝分裂细胞数大于4个分别显著增加了肿瘤复发风险率和死亡风险率(P<0.05)。在肿瘤ERs和PRs均为阴性的有淋巴结转移的IDC患者中,多变量分析显示血管内肿瘤栓子中凋亡细胞数大于2个显著增加了肿瘤复发和死亡风险率(P<0.005)。我们得出结论,血管内肿瘤细胞中的凋亡细胞数和有丝分裂细胞数是乳腺IDC患者非常重要的预后指标。